Cargando…

Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications

Over the past decade, ROS-sensitive formulations have been widely used in atherosclerosis applications such as ROS scavenging, drug delivery, gene delivery, and imaging. The intensified interest in ROS-sensitive formulations is attributed to their unique self-adaptive properties, involving the main...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Hao, Peng, Renyi, Jin, Libo, Ma, Jiahui, Yang, Qinsi, Sun, Da, Wu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468237/
https://www.ncbi.nlm.nih.gov/pubmed/34575528
http://dx.doi.org/10.3390/pharmaceutics13091452
_version_ 1784573613474578432
author Ji, Hao
Peng, Renyi
Jin, Libo
Ma, Jiahui
Yang, Qinsi
Sun, Da
Wu, Wei
author_facet Ji, Hao
Peng, Renyi
Jin, Libo
Ma, Jiahui
Yang, Qinsi
Sun, Da
Wu, Wei
author_sort Ji, Hao
collection PubMed
description Over the past decade, ROS-sensitive formulations have been widely used in atherosclerosis applications such as ROS scavenging, drug delivery, gene delivery, and imaging. The intensified interest in ROS-sensitive formulations is attributed to their unique self-adaptive properties, involving the main molecular mechanisms of solubility switch and degradation under the pathological ROS differences in atherosclerosis. This review outlines the advances in the use of ROS-sensitive formulations in atherosclerosis applications during the past decade, especially highlighting the general design requirements in relation to biomedical functional performance.
format Online
Article
Text
id pubmed-8468237
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84682372021-09-27 Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications Ji, Hao Peng, Renyi Jin, Libo Ma, Jiahui Yang, Qinsi Sun, Da Wu, Wei Pharmaceutics Review Over the past decade, ROS-sensitive formulations have been widely used in atherosclerosis applications such as ROS scavenging, drug delivery, gene delivery, and imaging. The intensified interest in ROS-sensitive formulations is attributed to their unique self-adaptive properties, involving the main molecular mechanisms of solubility switch and degradation under the pathological ROS differences in atherosclerosis. This review outlines the advances in the use of ROS-sensitive formulations in atherosclerosis applications during the past decade, especially highlighting the general design requirements in relation to biomedical functional performance. MDPI 2021-09-11 /pmc/articles/PMC8468237/ /pubmed/34575528 http://dx.doi.org/10.3390/pharmaceutics13091452 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ji, Hao
Peng, Renyi
Jin, Libo
Ma, Jiahui
Yang, Qinsi
Sun, Da
Wu, Wei
Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
title Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
title_full Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
title_fullStr Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
title_full_unstemmed Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
title_short Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
title_sort recent advances in ros-sensitive nano-formulations for atherosclerosis applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468237/
https://www.ncbi.nlm.nih.gov/pubmed/34575528
http://dx.doi.org/10.3390/pharmaceutics13091452
work_keys_str_mv AT jihao recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications
AT pengrenyi recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications
AT jinlibo recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications
AT majiahui recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications
AT yangqinsi recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications
AT sunda recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications
AT wuwei recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications